Ducommun Incorporated (DCO), a manufacturer of components for the aerospace, defense, and industrial markets, has delivered 22 consecutive quarters of year-over-year revenue growth. Its third-quarter 2026 report matters because it shows whether the company can sustain margin expansion while defense order timing creates short-term revenue noise. The results arrived against a backdrop of accelerating commercial aerospace production and rising defense budgets, both of which support Ducommun's VISION 2027 strategy. Investors were closely watching whether record bookings would translate into durable backlog growth and whether the company's engineered-product mix could keep pushing profitability higher heading into 2027. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
For the third quarter ended October 3, 2026, Ducommun reported record net revenue of $227.0 million, a roughly 6% increase from $214.4 million a year earlier and above the consensus estimate of about $222 million. Non-GAAP adjusted diluted EPS reached $1.21, edging past analyst expectations of approximately $1.15. Under generally accepted accounting principles (GAAP), diluted EPS was $0.89, compared with a loss of $4.06 per share in the prior-year quarter, which had been weighed down by a $99.7 million litigation settlement.
Gross margin expanded to a record 28.9%, up 140 basis points from 27.5% a year ago. Adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) rose to $39.7 million, or 17.5% of revenue, up from 17.4% in the prior-year period. Total bookings of $354 million produced a book-to-bill ratio of 1.6x, and remaining performance obligations climbed to a record $1.3 billion. Commercial aerospace revenue grew 28% year over year, while military and space revenue declined about 7% due to the timing of certain programs.
Shares remained roughly flat around $157 following the release, according to market data, reflecting a generally constructive but measured response to results that beat on both revenue and adjusted EPS. The record bookings and expanding gross margin were viewed positively, but a 7% decline in military and space revenue highlighted the quarter-to-quarter volatility caused by defense order timing. Investors appeared to weigh the strength of the backlog and margin trajectory against near-term segment softness, with sentiment supported by the company's narrowed full-year revenue guidance of $885 million to $890 million.
Ducommun's record remaining performance obligations of $1.3 billion set the stage for multi-year growth, particularly in defense. The company highlighted a $90 million order for the SPY-6 Navy radar and $54 million in bookings for the MESA airborne surveillance program supporting the Boeing E-7 Wedgetail, signaling that its radar franchise is strengthening alongside its established missile business.
Investors should watch whether the seven-year missile framework agreements between RTX and Lockheed Martin begin converting into purchase orders, with management indicating that flow-down orders could start in late first quarter or second quarter of 2027. On the commercial side, the destocking cycle is expected to wind down in December, which could further support aerospace rates. Margin trends will remain a focal point, given the company's progress toward its 2027 adjusted EBITDA target of 18% and its longer-term VISION 2032 goals of $1.6 billion to $1.7 billion in revenue and a 23% adjusted EBITDA margin. From what I see, this backlog visibility is important because it provides a clearer line of sight into 2027 and beyond.
In my view, staying on top of patterns across many names requires efficient tools. I regularly turn to Tickeron’s AI Screener when I want to quickly filter ideas by industry, technical signals, and performance metrics. It helps surface comparisons without hours of manual work and fits naturally into a broader research process for names like DCO.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where DCO advanced for three days, in 228 of 339 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where DCO's RSI Indicator exited the oversold zone, 8 of 15 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 53%.
DCO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 36 of 71 cases where DCO's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 51%.
The Momentum Indicator moved below the 0 level on November 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on DCO as a result. In 53 of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 57%.
The Moving Average Convergence Divergence Histogram (MACD) for DCO turned negative on November 04, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In 28 of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at 57%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DCO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 59%.
The Aroon Indicator for DCO entered a downward trend on November 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Profit vs. Risk Rating rating for this company is 18 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 44 (best 1 - 100 worst), indicating steady price growth. DCO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 68 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.419) is normal, around the industry mean (5.045). DCO has a moderately low P/E Ratio (-129.198) as compared to the industry average of (17.993). DCO's Projected Growth (PEG Ratio) (10.790) is slightly higher than the industry average of (3.110). Dividend Yield (0.002) settles around the average of (0.058) among similar stocks. P/S Ratio (3.001) is also within normal values, averaging (18.367).
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of aircraft components and equipment
Industry AerospaceDefense